Cancer resources for healthcare providers
Approximately 5-10% of all cancer is due to hereditary cancer syndromes. More cancers are likely influenced by genetic factors associated with moderate risk. Being able to identify individuals at increased cancer risk through family history and, in some cases, genetic testing, can influence management and outcomes through increasing screening and/or risk-reducing interventions. The resources below provide opportunities to learn about hereditary cancer syndromes, identify individuals at increased risk, interpret genetic testing results, apply genetic information to management, collaborate with genetics professionals, and communicate with patients.
Familial Adenomatous Polyposis Factsheet. Describes the clinical features, diagnosis, testing and genetics of familial adenomatous polyopsis (FAP) and attenuated FAP.
Hereditary Breast and Ovarian Cancer Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of hereditary breast and ovarian cancer (HBOC) syndrome.
Lynch Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
MUTYH-Associated Adenomatous Polyposis Factsheet. Describes the clinical features, diagnosis, testing and genetics of MUTYH-associated polyposis (MAP).
Accessing Genetic Services Tool. Lists tools and websites to help find genetics professionals and provides patient talking points about referring to genetics.
Breast Cancer Risk and Screening Guidelines Factsheet. Summarizes screening guidelines for patients at average, increased, and high genetic risk for breast cancer.
Cancer Risk Assessment Tool. Helps identify red flags and stratify cancer risk based on family history.
Cancer Screening Factsheet. Summarizes professional society guidance about screening for individuals at average, increased, and high risk for breast, prostate, and colorectal cancer.
Communicating Risk Factsheet. Outlines key points to consider when communicating risk to patients.
Components of a Cancer Genetic Counseling Session Factsheet. Discusses the core components of a cancer genetic counseling session.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Family History Questionnaire. A collection form for medical family history data that can be printed and used in clinical practice.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes (enhanced e-book available for download).
Inheritance Patterns Factsheet. Outlines common inheritance patterns of conditions with an underlying genetic component.
Pedigree Tool. A template to record a pedigree with standard pedigree nomenclature.
Pretest Counseling Key Points Factsheet. Outlines key points to address during pretest counseling.
Targeted Colorectal and Polyp Family History Tool. Lists key questions and guidance for collecting a family history targeted toward colorectal cancer.
Genomic Technologies for Oncologists eBook. Provides an overview of genomic technologies used in cancer research and clinical care (enhanced e-book available for download).
Hereditary Breast Cancer Patient and Family Resources. Provides patient resources for understanding genetic services and breast cancer genetics.
Free, self-directed programs for continuing education credit.
Practice asking the right questions to elicit enough information to assess family history disease risk and get tools to implement your skills.
Access CME Module | Access CNE Module
Analyze family histories and classify patients' risk into average, increased (moderate), or high risk for cancer.
Access CME Module | Access CNE Module
Practice determining appropriate management based on family history risk stratification.
Access CME Module | Access CNE Module
Practice identifying risk factors in case scenarios and receive tools to help make this task easy to implement in your practice.
Access CME Module | Access CNE Module
Practice deciding when and if genetic testing is appropriate given a patient's clinical and personal context.
Access CME Module | Access CNE Module
Practice interpreting genetic testing results within a patient's specific context.
Access CME Module | Access CNE Module
Practice weighing the benefits, risks, and limitations of different tests within specific patient contexts.
Access CME Module | Access CNE Module
Practice evaluating how well a particular genetic test assesses breast cancer risk and the potential impact of testing on patient outcomes.
Access CME Module | Access CNE Module
Practice evaluating the fit between a patient's history and a particular genetic test for hereditary colorectal cancer syndromes.
Access CME Module | Access CNE Module
Learn how to identify, evaluate, and manage patients at increased risk of HBOC.
Access CME Module
Learn how to determine when somatic cancer panel testing is appropriate for your patients and how to interpret results of such testing.
Access CME Module | Access CNE Module
Learn how to identify important test characteristics, compare and contrast offerings from different labs, find actionable information on the test report, and interpret results in the context of the individual patient.
Access CME Module | Access CNE Module
Immunologically humanized NSGTM and its variant strains are a powerful system that facilitates cutting-edge in vivo preclinical testing of...
A JAX team developed CUP-AI-Dx, a machine learning tool that uses RNA sequence data for analysis. The researchers show that...
PDX models provide researchers with the ability to work with tumors directly from patients within a living (in vivo) system, making them a...
The Jackson Laboratory provides the most widely published and cutting-edge models for oncology research and offers a comprehensive suite of...
Online Resources for Cancer Research
There are hundreds of JAX® Mice strains available for cancer research and drug efficacy testing. The table below summarizes...
Onco-Hu® models are a robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells to...
Cutting Edge Bioinformatics for Preclinical Oncology. Dig deeper to understand tumor response or resistance to your...
Cutting edge sequencing for preclinical oncology.
Patient-derived tumor xenografts in humanized NSG™ and NSG™-SGM3 mice
The JAX ActionSeq™ test is a targeted panel of 212 cancer related genes analyzed using next-generation sequencing. The panel assesses all...
The JAX Cancer Treatment Profile™ is a targeted panel of 358 cancer related genes and 53 genes known to form fusions associated with...
Every patient is unique. So is every patient’s tumor. This one pager explains how advances in high-throughput molecular diagnostics now...
Resource to find local cancer genetics experts.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.